Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD and Urea for Neuropathic Pain in Diabetic Foot Neuropathy
NCT07162454Completed
- Sponsor
- Complutense University of Madrid
- Start
- Nov 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Randomised, triple-blind trial of Zygel in diabetic peripheral neuropathy (DPN) (3 arms), sponsored by Complutense University of Madrid. Primary endpoint: Assessment of neuropathic pain at 1 month. Started Nov 2024; status: completed.
02
Drugs
Zygel
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07162454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07162454.